Xadago as Add-on Therapy Eases Sleep Disturbances, Pilot Study Finds

Xadago as Add-on Therapy Eases Sleep Disturbances, Pilot Study Finds

302603

Xadago as Add-on Therapy Eases Sleep Disturbances, Pilot Study Finds

Three months of Xadago (safinamide) as an add-on therapy lessened symptoms of rapid eye movement sleep behavior disorder (RBD) in people with Parkinson’s disease, a pilot study in patients reported. The study, “Effects of safinamide on REM sleep behavior disorder in Parkinson disease: A randomized, longitudinal, cross-over pilot study,” was published in the Journal of Clinical Neuroscience. Parkinson’s presents with a variety of motor and non-motor symptoms, including such sleep disturbances as RBD. During RBD, a person…

You must be logged in to read/download the full post.